Over 200 tests for every batch: Bharat Biotech on Covaxin quality concern

Each batch of the vaccine was subjected to more than 200 quality control tests at its facilities, followed by submission samples to CDL. Only based on approval by CDL are batches released commercially

from Companies https://ift.tt/3rWAHRV
via IFTTT